Cargando…
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
BACKGROUND: Glioblastoma is a paradigm of cancer‐associated immunosuppression, limiting the effects of immunotherapeutic strategies. Thus, identifying the molecular mechanisms underlying immune surveillance evasion is critical. Recently, the preferential expression of inhibitory natural killer (NK)...
Autores principales: | Di, Wang, Fan, Wenhua, Wu, Fan, Shi, Zhongfang, Wang, Zhiliang, Yu, Mingchen, Zhai, You, Chang, Yuanhao, Pan, Changqing, Li, Guanzhang, Kahlert, Ulf Dietrich, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819299/ https://www.ncbi.nlm.nih.gov/pubmed/34881489 http://dx.doi.org/10.1111/cas.15236 |
Ejemplares similares
-
Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021) -
Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
por: Li, Guanzhang, et al.
Publicado: (2021) -
TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023) -
A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Feng, Yuemei, et al.
Publicado: (2020) -
The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules
por: Rother, Sascha, et al.
Publicado: (2015)